Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fruquintinib, Pirfenidone, and Pembrolizumab in Advanced Colorectal Cancer
NCT06484153Phase 2Recruiting
- Start
- Jul 2024
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
A Phase 2 trial of pirfenidone in colorectal adenocarcinoma. Started Jul 2024; status: recruiting.
02
Drugs
pirfenidone
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on NCT06484153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06484153.